Elanco Animal Health ( (ELAN) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Elanco Animal Health shares moved lower even as the company reported broad-based growth and outlined plans for faster debt reduction under its Elanco Ascend cost program. Investors appeared cautious despite management also raising its 2026 innovation basket outlook to $1.15 billion and offering upbeat long-term guidance.
The company projected 2026 revenue between $4.95 billion and $5.02 billion, with adjusted EBITDA expected to reach $955 million to $985 million. Following the update, analysts responded by lifting their price targets on Elanco, signaling confidence in the firm’s strategy despite the stock’s recent drop.
More about Elanco Animal Health
YTD Price Performance: 11.36%
Average Trading Volume: 5,019,967
Technical Sentiment Signal: Buy
Current Market Cap: $12.31B
For further insights into ELAN stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.